Peter Diamandis Launches NeoGenesis Capital to Back Colossal's Programmable Biology Spinouts
PeterDiamandis · x · 2026-10-15
Peter Diamandis announces NeoGenesis Capital, co-founded with Yianni Psaltis. The fund builds on his early bet on Colossal Biosciences, whose platform — built by Ben Lamm and George Church at the intersection of superintelligence and synthetic biology — can engineer living products. NeoGenesis will invest in Colossal and its spinout companies across food, environment, entertainment, security, and species reconstruction.
More from Venture
- Tessara opens up: specialist AI agents that investigate your stock theses — tengyanAI · 2026-10-15
- a16z gutted its 34-person talent team, signaling tougher times ahead — SumitGup · 2026-10-15
- Thrive Capital partner: if you're AGI-pilled, you should be long healthcare — HealthcareAIGuy · 2026-10-15
- This 17-year bull market is up 1,073% — I/O Fund expects a correction first — Beth_Kindig · 2026-10-15
- Micron has returned 1,230% in three years, beating Nvidia, AMD and Broadcom 3-4x — Beth_Kindig · 2026-10-15
- Apple closes above $5 trillion market cap, second company in history to hit the mark — Polymarket · 2026-10-15